Using the Rox index for Nasal High Flow therapy in patients with interstitial lung disease and severe acute respiratory failure.

A. Cysneiros (Lisboa, Portugal), D. Organista (Lisboa, Portugal), D. Machado (Gaia, Portugal), D. Rodrigues (Gaia, Portugal), F. Lopes (Santa Maria da Feira, Portugal), C. Antunes (Lisboa, Portugal), F. Paula (Lisboa, Portugal), F. Froes (Lisboa, Portugal)

Source: Virtual Congress 2020 – Novel findings regarding acute respiratory distress syndrome, extra corporeal membrane oxygenation and weaning from mechanical ventilation
Disease area: Respiratory critical care

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Cysneiros (Lisboa, Portugal), D. Organista (Lisboa, Portugal), D. Machado (Gaia, Portugal), D. Rodrigues (Gaia, Portugal), F. Lopes (Santa Maria da Feira, Portugal), C. Antunes (Lisboa, Portugal), F. Paula (Lisboa, Portugal), F. Froes (Lisboa, Portugal). Using the Rox index for Nasal High Flow therapy in patients with interstitial lung disease and severe acute respiratory failure.. 3446

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High flow nasal cannula in patients awaiting lung transplantation with acute respiratory failure exacerbations resulting from interstitial lung disease. Series of cases
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016


Evaluation of nasal optiflow device in management of COPD patients in acute exacerbations
Source: International Congress 2015 – Acute critical care: COPD, muscles and weaning
Year: 2015

High flow nasal therapy in hypercapnic acute respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


Nasal high flow versus Non-invasive ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2019 – Treatment of acute respiratory failure with noninvasive ventilation
Year: 2019

Non-invasive ventilation in the management of acute respiratory failure in patients with idiopathic pulmonary fibrosis
Source: International Congress 2014 – Expanding the use of noninvasive ventilation in acute respiratory failure
Year: 2014

High flow nasal cannula therapy improves clinical and gas exchange parameters in children with acute bronchiolitis
Source: Annual Congress 2013 –Neonatal and paediatric intensive care
Year: 2013


Non-invasive ventilation (NIV) in acute respiratory failure in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015


Walking assessments as the predictor of acute respiratory failure in the interstitial lung disease patients.
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020


Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure.
Source: Eur Respir J 2002; 20: 790
Year: 2002


Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Home high flow oxygen therapy for chronic lung disease of prematurity
Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Year: 2016


Outcome predictors of noninvasive ventilation in patients with respiratory failure due to chronic obstructive pulmonary disease
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016

PaO2/FiO2 with low PEEP using NPPV is a significant predictor on survival in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Rituximab treatment of a case of anti-syntetase syndrome with severe interstitial lung disease and acute respiratory failure
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010


Non invasive ventilation in acute respiratory failure due to COPD vs non COPD conditions: Effectiveness and failure predictors
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015


Predicting factors for the failure of high flow nasal cannula therapy in patients with acute respiratory failure
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018


Predictors of failure of noninvasive ventilation (NIV) in acute respiratory failure due to chronic obstructive pulmonary disease
Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications
Year: 2013

Noninvasive ventilation in acute respiratory failure caused by non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: notable points
Year: 2015


Factors related with non-invasive ventilation success in chronic obstructive pulmonary disease
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015


Evaluation of mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015